DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
about
Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancerMolecular profiling of thyroid cancer subtypes using large-scale text mining.Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.A novel analysis strategy for integrating methylation and expression data reveals core pathways for thyroid cancer aetiology.REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer.Downregulation of ADAMTS8 by DNA Hypermethylation in Gastric Cancer and Its Clinical Significance.Placental pseudo-malignancy from a DNA methylation perspective: unanswered questions and future directions.Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis.Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype.Medullary thyroid carcinoma: a 25-year perspective.Epigenetic modifications in human thyroid cancer.Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis.Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors.The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.The Genes of Life and Death: A Potential Role for Placental-Specific Genes in Cancer: Active retrotransposons in the placenta encode unique functional genes that may also be used by cancer cells to promote malignancy.Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis.DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.Evaluation of PACE4 isoforms as biomarkers in thyroid cancerThyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates
P2860
Q33629836-FF64EB5B-C055-486E-B2CD-D36A54B6621DQ33841409-5FBCA66A-76F9-4F99-BE57-9D40C1126CDDQ34914970-3CC1EC8E-63FC-4666-9EA5-76B2CD206C39Q35000289-D392A1F5-5618-45E1-B342-B56375172ABEQ35871560-6518C268-6CE1-482C-B2EE-768C6973CCE5Q36629559-8A8CECBB-0566-4A04-A288-02B382EE8809Q37132363-FBF0C550-85D7-4903-82C4-A160AFFDB699Q37379983-F24ABE63-CDF0-4C41-8922-80CB12EC08B3Q37475506-39370215-401F-40DB-A8D8-A4734E823915Q37554758-04DE4B47-B235-44DC-9E5E-2BB9CA6D3634Q38171726-FBF98ADE-5060-4984-B6E8-B581DC344E5FQ38282099-B7354946-8E73-4C54-8EF0-EDA330DF0324Q38441002-5CA5DE72-BB06-41A0-AF53-53B8DAEAA376Q38673964-0B2CD9A2-E7BF-4EF9-AAAB-75ED0309B696Q38894925-50FB14EC-6F84-4772-8529-76A40D8294D7Q43473087-44A868D5-B85E-479C-96B1-B70FCD34A49AQ47098782-09B54ECD-6F8F-4499-A033-7EF209660BA8Q47122756-EF33CCC0-7820-4FE1-8793-A22EB9F7F573Q48334688-BF892048-8FDF-4DD3-8BA9-39AF9A27EA22Q49626629-073AF23E-2D55-49DC-9271-37E50A733B1FQ54171874-6FC55BE8-D875-4EE9-B36B-5F189911FEB0Q54387117-88B9C669-0FD9-4EDB-A153-2F15481CCB59Q55227686-36463EDC-89F5-4496-A351-802518B07673Q55472371-4E9CF5D4-BD2F-46D2-B371-3B8F0FCCBA0FQ57810683-1890586D-FC53-4DA8-9CD7-1EC41B287F88Q58796314-60A9E6A5-5139-485A-B156-D684B8E987F8
P2860
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
@en
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
@nl
type
label
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
@en
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
@nl
prefLabel
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
@en
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
@nl
P2093
P50
P356
P1476
DNA methylation signatures identify biologically distinct thyroid cancer subtypes
@en
P2093
Carlos Suarez
Cecilia Ferrero
Gustavo F Bayon
Juan Luís Fernández-Morera
Manuel Florentino Fresno Forcelledo
Mario F Fraga
Marta Mendiola
Pablo Isidro Marrón
Veronika Mancikova
Xavier Matías-Guiu
P304
P356
10.1210/JC.2012-3566
P407
P50
P577
2013-05-10T00:00:00Z